Showing results (51-60 of 548) with videos related to
Sort By:
Pageof 55
Diabetes, Obesity & Metabolism|June 4, 2010
Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?T Sathyapalan, S L Atkin, E S KilpatrickDiabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target settingT Sathyapalan, S L Atkin, E S KilpatrickEndocrine, Metabolic & Immune Disorders Drug Targets|October 16, 2019
A Review on the Effects of New Anti-Diabetic Drugs on Platelet FunctionHabib Yaribeygi, Stephen L Atkin, Tannaz Jamialahmadi, et al.Journal of the American Academy of Audiology|January 1, 1995
Alport syndrome: clinical updateD C Wester, C L Atkin, M C GregoryMolecular & General Genetics : MGG|March 1, 1990
The functional organization of the vestigial locus in Drosophila melanogasterJ A Williams, A L Atkin, J B BellAnnals of Internal Medicine|February 1, 1978
Hereditary nephritis: a re-examination of its clinical and genetic featuresW M O'Neill, C L Atkin, H A BloomerThe Journal of Reproductive Medicine|March 9, 2002
Use of dynamic contrast-enhanced MRI to assess the functional vascular pharmacokinetic parameters of normal human ovariesGlen H Hall, Stephen L Atkin, Lindsay W TurnbullEnvironmental Pollution (Barking, Essex : 1987)|July 5, 2005
Assessment of the ecological potential of mine-water treatment wetlands using a baseline survey of macroinvertebrate communitiesL C Batty, L Atkin, D A C ManningFuture Microbiology|December 10, 2009
Cellular interactions of farnesol, a quorum-sensing molecule produced by Candida albicansMelanie L Langford, Audrey L Atkin, Kenneth W NickersonPharmacological Research|October 14, 2018
Effects of curcumin on hypoxia-inducible factor as a new therapeutic targetAfsane Bahrami, Stephen L Atkin, Muhammed Majeed, et al.Pageof 55